This event is not part of the official AAFP FMX
Saturday, October 28, 2023
6:00 AM – 6:15 AM: Registration and Breakfast
6:15 AM – 7:30 AM: Symposium
Marriott Marquis Chicago
2121 South Prairie Avenue
Chicago, IL 60616
Meeting Room: Grand Horizon C, 4th Floor
PROGRAM FEATURES
- Interactive, case-based learning environment
- Downloadable Simulation Challenge
- Create your own Personalized Poster
FACULTY
 |
Charles Vega, MD, FAAFP Health Sciences Clinical Professor Department of Family Medicine Assistant Dean for Culture and Community Education UC Irvine School of Medicine Irvine, CA |
 |
Michael J. Blaha, MD, MPH Professor of Medicine and Epidemiology Director of Clinical Research Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore, MD |
PROGRAM OVERVIEW
This innovative educational symposium is designed to advance interdisciplinary collaboration among clinicians who manage patients with cardio-renal-metabolic comorbidities. Using a combination of didactic lecture and simulation case challenges tailored to a primary audience of primary care physicians and a secondary audience of cardiologists, nephrologists, endocrinologists, hospitalists, physician assistants, nurse practitioners, pharmacists, and certified diabetes educators, this program aims to increase clinician knowledge of the application of SGLT2 inhibitors to the management of heart failure and chronic kidney disease as well as improve their ability to effectively communicate with all members of the multidisciplinary care team to optimize patient care.
LEARNING OBJECTIVES
- Apply SGLT2 inhibitors to the management of heart failure and/or chronic kidney disease using relevant guidelines, clinical evidence, and FDA-approved indications
- Develop and utilize strategies for timely diagnosis and/or prompt treatment initiation in patients diagnosed with chronic kidney disease (CKD)
- Exhibit proficient collaboration and communication skills when working with endocrinologists, cardiologists, and nephrologists to employ a multidisciplinary care approach for patients with comorbidities involving the cardiovascular, renal, and metabolic systems
TARGET AUDIENCE
This educational activity is intended for primary audience of Primary Care Physicians, and a secondary audience of Cardiologists, Nephrologists, Endocrinologists, Hospitalists, Physician Assistants, Nurse Practitioners, Pharmacists, and Certified Diabetes Educators.
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this activity for a maximum of 1.25 ANCC contact hours.
AAFP ACCREDITATION
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
COMMISION ON DIETETIC REGISTRATION
This program is seeking prior approval with the Commission on Dietetic Registration for dietitians and RDs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]
